Politico March 7, 2025
WASHINGTON WATCH
“There’s a number of opportunities with AI right now that we have that we’ve never had before,” Dr. Marty Makary, President Donald Trump’s nominee to lead the Food and Drug Administration, told a panel of lawmakers he hopes will confirm him.
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, Labor and Pensions Committee. He was quick to add that AI would assist reviewers, not replace them.
He also said AI could be used to aid with data monitoring after a drug has been approved. “So that we don’t learn five years after Vioxx was approved that 38,000 Americans died from it,” he said.
Today's Sponsors
Today's Sponsor